Impact of the short-term, intense exercise on postprandial glycemia in type 2 diabetic patients treated with gliclazide

Journal of Diabetes and its Complications

Volumn 21, Issue 2, 2007, Pages 101-107

  Szewieczek, Jan ^a   Dulawa, Jan ^a   Strzałkowska, Dorota ^a   Hornik, Beata ^a   Kawecki, Grzegorz ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Gliclazide; Standard treadmill testing; Submaximal intense exercise; Sulphonylurea; Type 2 diabetes

Indexed keywords

CATECHOLAMINE; GLICLAZIDE; GLUCOSE; GROWTH HORMONE; HYDROCORTISONE; LACTIC ACID;

ADULT; ARTICLE; CATECHOLAMINE BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; GLUCAGON BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GROWTH HORMONE BLOOD LEVEL; HUMAN; HYDROCORTISONE BLOOD LEVEL; INSULIN BLOOD LEVEL; KINESIOTHERAPY; LACTATE BLOOD LEVEL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SHORT COURSE THERAPY; TREADMILL EXERCISE;

ADULT; AGED; ANALYSIS OF VARIANCE; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; EPINEPHRINE; EXERCISE; EXERCISE TEST; GLICLAZIDE; GLUCAGON; GROWTH HORMONE; HUMANS; HYDROCORTISONE; HYPOGLYCEMIC AGENTS; INSULIN; LACTATES; MALE; MIDDLE AGED; NOREPINEPHRINE; POSTPRANDIAL PERIOD; TIME FACTORS;

EID: 33847206118     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2006.05.006     Document Type: Article

References (42)

1. Bavenholm P.N., Pigon J., Ostenson C.G., and Efendic S. Insulin sensitivity of suppression of endogenous glucose production is the single most important determinant of glucose tolerance. Diabetes 50 (2001) 1449-1454
2. Berger C.M., Sharis P.J., Bracy D.P., Lacy D.B., and Wasserman D.H. Sensitivity of exercise-induced increase in hepatic glucose production to glucose supply and demand. American Journal of Physiology 267 (1994) E411-E421
3. Berger D., Floyd Jr. J.C., Lampman R.M., and Fajans S.S. The effect of adrenergic receptor blockade on the exercise-induced rise in pancreatic polypeptide in man. Journal of Clinical Endocrinology and Metabolism 50 (1980) 33-39
4. Bloom S.R., Johnson R.H., Park D.M., Rennie M.J., and Sulaiman W.R. Differences in the metabolic and hormonal response to exercise between racing cyclists and untrained individuals. Journal of Physiology 258 (1976) 1-18
5. Bolli G.B., Gottesman I.S., Cryer P.E., and Gerich J.E. Glucose counterregulation during prolonged hypoglycemia in normal humans. American Journal of Physiology 247 (1984) E206-E214
6. Bonora E., Kiechl S., Willeit J., Oberhollenzer F., Egger G., Targher G., et al. Prevalence of insulin resistance in metabolic disorders: The Bruneck Study. Diabetes 47 (1998) 1643-1649
7. Boule N.G., Haddad E., Kenny G.P., Wells G.A., and Sigal R.J. Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: A meta-analysis of controlled clinical trials. Scandinavian Journal of Medicine & Science in Sports 12 (2002) 60-61
8. Brenner I.K., Zamecnik J., Shek P.N., and Shephard R.J. The impact of heat exposure and repeated exercise on circulating stress hormones. European Journal of Applied Physiology and Occupational Physiology 76 (1997) 445-454
9. Consoli A., Nurjhan N., Capani F., and Gerich J. Predominant role of gluconeogenesis in increased hepatic glucose production in NIDDM. Diabetes 38 (1989) 550-557
10. Cryer P.E., Davis S.N., and Shamoon H. Hypoglycemia in diabetes. Diabetes Care 26 (2003) 902-912
11. Dietze G., Wicklmayr M., Hepp K.D., Bogner W., Mehnert H., Czempiel H., et al. On gluconeogenesis of human liver. Accelerated hepatic glucose formation induced by increased precursor supply. Diabetologia 12 (1976) 555-561
12. Eriksson J., Franssila-Kallunki A., Ekstrand A., Saloranta C., Widen E., Schalin C., et al. Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. New England Journal of Medicine 321 (1989) 337-343
13. Fletcher G.F., Balady G., Froelicher V.F., Hartley L.H., Haskell W.L., and Pollock M.L. Exercise standards. A statement for healthcare professionals from the American Heart Association. Circulation 91 (1995) 580-615
14. Galbo H., Christensen N.J., and Holst J.J. Catecholamines and pancreatic hormones during autonomic blockade in exercising man. Acta Physiologica Scandinavica 101 (1977) 428-437
15. Gastaldelli A., Baldi S., Pettiti M., Toschi E., Camastra S., Natali A., et al. Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans: A quantitative study. Diabetes 49 (2000) 1367-1373
16. Gibbons R.J., Balady G.J., Beasley J.W., Bricker J.T., Duvernoy W.F.C., Froelicher V.F., et al. ACC/AHA guideline for exercise testing: Executive summary. Circulation 96 (1997) 345-354
17. Helmrich S.P., Ragland D.R., Leung R.W., and Paffenbarger Jr. R.S. Physical activity and reduced occurrence of non-insulin-dependent diabetes mellitus. New England Journal of Medicine 325 (1991) 147-152
18. Jenssen T., Nurjhan N., Consoli A., and Gerich J.E. Failure of substrate-induced gluconeogenesis to increase overall glucose appearance in normal humans. Demonstration of hepatic autoregulation without a change in plasma glucose concentration. Journal of Clinical Investigation 86 (1990) 489-497
19. Kjaer M., Hollenbeck C.B., Frey-Hewitt B., Galbo H., Haskell W., and Reaven G.M. Glucoregulation and hormonal responses to maximal exercise in non-insulin-dependent diabetes. Journal of Applied Physiology 68 (1990) 2067-2074
20. Kowalska I., Prokop J., Bachorzewska-Gajewska H., Telejko B., Kinalska I., Kochman W., et al. Disturbances of glucose metabolism in men referred for coronary arteriography. Postload glycemia as predictor for coronary atherosclerosis. Diabetes Care 24 (2001) 897-901
21. Larsen J.J., Dela F., Kjaer M., and Galbo H. The effect of moderate exercise on postprandial glucose homeostasis in NIDDM patients. Diabetologia 40 (1997) 447-453
22. Levy C.J., Kinsley B.T., Bajaj M., and Simonson D.C. Effect of glycemic control on glucose counterregulation during hypoglycemia in NIDDM. Diabetes Care 21 (1998) 1330-1338
23. Marker J.C., Hirsch I.B., Smith L.J., Parvin C.A., Holloszy J.O., and Cryer P.E. Catecholamines in prevention of hypoglycemia during exercise in humans. American Journal of Physiology 260 (1991) E705-E712
24. Marliss E.B., and Vranic M. Intense exercise has unique effects on both insulin release and its roles in glucoregulation. Diabetes 51 (2002) S271-S283
25. Martin I.K., Katz A., and Wahren J. Splanchnic and muscle metabolism during exercise in NIDDM patients. American Journal of Physiology 269 (1995) E583-E590
26. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
27. Mikines K.J., Sonne B., Farrell P.A., Tronier B., and Galbo H. Effect of physical exercise on sensitivity and responsiveness to insulin in humans. American Journal of Physiology 254 (1988) E248-E259
28. Mitchell T.H., Abraham G., Schiffrin A., Leiter L.A., and Marliss E.B. Hyperglycemia after intense exercise in IDDM subjects during continuous subcutaneous insulin infusion. Diabetes Care 11 (1988) 311-317
29. Monnier L., Colette C., Rabasa-Lhoret R., Lapinski H., Caubel C., Avignon A., et al. Morning hyperglycemic excursions: A constant failure in the metabolic control of non-insulin-using patients with type 2 diabetes. Diabetes Care 25 (2002) 737-741
30. Musi N., Fujii N., Hirshman M.F., Ekberg I., Froberg S., Ljungqvist O., et al. AMP-activated protein kinase (AMPK) is activated in muscle of subjects with type 2 diabetes during exercise. Diabetes 50 (2001) 921-927
31. Nugent A.M., Steele I.C., Al-Modaris F., Vallely A., Campbell N.P.S., Bell P.M., et al. Exercise responses in patients with IDDM. Diabetes Care 20 (1997) 1814-1821
32. Raskin P., and Unger R.H. Hyperglucagonemia and its suppression. Importance in the metabolic control of diabetes. New England Journal of Medicine 299 (1978) 433-436
33. Richter E.A., Ruderman N.B., and Schneider S.H. Diabetes and exercise. American Journal of Medicine 70 (1981) 201-209
34. Riddle M.C., McDaniel P.A., and Tive L.A. Glipizide-GITS does not increase the hypoglycemic effect of mild exercise during fasting in NIDDM. Diabetes Care 20 (1997) 992-995
35. Segel S.A., Paramore D.S., and Cryer P.E. Hypoglycemia-associated autonomic failure in advanced type 2 diabetes. Diabetes 51 (2002) 724-733
36. Shaughnessy A.F., and Slawson D.C. What happened to the valid POEMs? A survey of review articles on the treatment of type 2 diabetes. British Medical Journal 327 (2003) 266
37. Stepka M., Rogala H., and Czyzyk A. Hypoglycemia: A major problem in the management of diabetes in the elderly. Aging 5 (1993) 117-121
38. The Expert Committee on the Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 21 (1998) 5S-19S
39. Tillil H., Frank B.H., Pekar A.H., Broelsch C., Rubenstein A.H., and Polonsky K.S. Hypoglycemic potency and metabolic clearance rate of intravenously administered human proinsulin and metabolites. Endocrinology 127 (1990) 2418-2422
40. Turgan N., Coker C., Hamulu F., Elmaci S., Yilmaz C., Ersoz B., et al. Glucose metabolism and catecholamine responses during physical exercise in non-insulin-dependent diabetes. European Journal of Clinical Chemistry and Clinical Biochemistry 34 (1996) 683-689
41. Ward W.K. Disproportionate elevation of immunoreactive proinsulin in type 2 (non-insulin-dependent) diabetes mellitus and in experimental insulin resistance. Diabetologia 30 (1987) 698-702
42. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO Consultation. WHO/NCD/NCS/99.2 (1999), World Health Organization, Geneva